Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations

Keyphrases

• Temozolomide 100%
• Adult Gliomas 100%
• Nave 50%
• Hypermutated Tumor 50%
• Glioma Patients 25%
• Hypermutation 25%
• Immunotherapeutics 12%
• Oncogenesis 12%
• Methylation 12%
• Tumor Subtype 12%
• Cancer Development 12%
• Germ Cells 12%
• Glioma 12%
• Somatic mutation 12%
• Family Members 12%
• Glioblastoma 12%
• Mismatch Repair 12%
• DNA Repair Pathways 12%
• Direct Results 12%
• Whole Exome Sequencing 12%
• Isocitrate Dehydrogenase 1 (IDH1) 12%
• Genetic Predisposition 12%
• Hereditary Risk 12%
• Glioma Therapy 12%
• Whole Transcriptome Sequencing 12%
• Development History 12%
• Single-cell RNA Sequencing (scRNA-seq) 12%
• Genomic Traits 12%
• Hypermutator 12%
• Mutagenic Processes 12%
• MGMT Promoter 12%
• Mismatch Repair Pathway 12%
• Induced mutagenesis 12%
• Neoantigen Load 12%
• Hypermutated 12%

Immunology and Microbiology

• Mismatch Repair 100%
• Promoter Region 50%
• Immunotherapy 50%
• DNA Repair 50%
• Somatic Mutation 50%
• Methylation 50%
• Mutagenesis 50%
• RNA Sequencing 50%
• Genetic Predisposition 50%
• Whole Exome Sequencing 50%
• Neoantigen 50%
• Single-Cell Sequencing 50%
• Germ Cell 50%

Medicine and Dentistry

• Ganglioglioma 100%
• Temozolomide 100%
• Neoplasm 62%
• DNA Mismatch Repair 25%
• Malignant Neoplasm 12%
• Promoter Region 12%
• DNA Repair 12%
• Methylation 12%
• Carcinogenesis 12%
• Immunotherapy 12%
• Glioblastoma 12%
• Mutagenesis 12%
• Somatic Mutation 12%
• RNA Sequencing 12%
• Exome Sequencing 12%
• Genetic Predisposition 12%
• Germ Cell 12%